AXA S.A. - MACROGENICS INC ownership

MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 129 filers reported holding MACROGENICS INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
AXA S.A. ownership history of MACROGENICS INC
ValueSharesWeighting
Q2 2023$723,053
-25.4%
135,1500.0%0.00%
-33.3%
Q1 2023$969,026
+6.9%
135,1500.0%0.00%0.0%
Q4 2022$906,857
-3.1%
135,150
-50.0%
0.00%
+50.0%
Q3 2022$935,619
+17.3%
270,3000.0%0.00%
+100.0%
Q2 2022$797,693
-76.1%
270,300
-28.6%
0.00%
-80.0%
Q1 2022$3,337,614
+1267.9%
378,800
+2392.1%
0.01%
+400.0%
Q4 2021$244,000
-86.6%
15,200
-82.5%
0.00%
-80.0%
Q3 2021$1,820,000
-67.0%
86,900
-57.7%
0.01%
-37.5%
Q2 2021$5,512,000
+1.0%
205,200
+19.7%
0.01%
-52.9%
Q1 2021$5,459,000
+1037.3%
171,400
+716.2%
0.02%
+750.0%
Q4 2020$480,000
-73.3%
21,000
-67.4%
0.00%
-50.0%
Q2 2020$1,798,000
-12.2%
64,400
-81.7%
0.00%
-20.0%
Q1 2020$2,048,000
-46.5%
352,0000.0%0.01%
-37.5%
Q4 2019$3,830,000
-14.7%
352,0000.0%0.01%
-11.1%
Q3 2019$4,492,000
-25.8%
352,000
-1.3%
0.01%
-25.0%
Q2 2019$6,054,000
+392.6%
356,800
+421.8%
0.01%
+140.0%
Q1 2019$1,229,000
+41.6%
68,3740.0%0.01%
+25.0%
Q4 2018$868,000
-46.1%
68,374
-8.9%
0.00%
-33.3%
Q3 2018$1,610,000
+306.6%
75,074
+291.0%
0.01%
+200.0%
Q2 2018$396,000
+51.1%
19,200
+35.2%
0.00%
+100.0%
Q3 2017$262,000
-5.4%
14,200
+94.5%
0.00%0.0%
Q2 2015$277,0007,3000.00%
Other shareholders
MACROGENICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Boxer Capital, LLC 2,200,000$40,656,0009.26%
INTERWEST VENTURE MANAGEMENT CO 1,074,316$19,854,0005.17%
DAFNA Capital Management LLC 154,200$2,850,0001.77%
Mesirow Financial Investment Management, Inc. 15,747$291,0001.37%
BB BIOTECH AG 2,400,412$44,360,0001.23%
Aviva Holdings Ltd. 115,914$2,142,0001.11%
First Light Asset Management, LLC 151,670$2,803,0000.89%
Bellevue Group AG 433,299$8,007,0000.84%
TIGER MANAGEMENT L.L.C. 239,667$4,429,0000.80%
Hood River Capital Management LLC 588,799$10,881,0000.69%
View complete list of MACROGENICS INC shareholders